{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:36:29Z","timestamp":1790750189516,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00277-020-04039-w","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T12:22:38Z","timestamp":1587730958000},"page":"1321-1330","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Prognostic role of baseline 18F-FDG PET\/CT metabolic parameters in elderly HL: a two-center experience in 123 patients"],"prefix":"10.1007","volume":"99","author":[{"given":"Domenico","family":"Albano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Mazzoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Spallino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Muzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio Ruggiero","family":"Zilioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Giubbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"key":"4039_CR1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s11899-011-0089-7","volume":"6","author":"TV Halbsguth","year":"2011","unstructured":"Halbsguth TV, B\u00f6ll B, Borchmann P, Diehl V (2011) The unique characteristics and management of patients over 60 years of age with classic Hodgkin lymphoma. Curr Hematol Malig Rep 6:164\u2013171","journal-title":"Curr Hematol Malig Rep"},{"key":"4039_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.critrevonc.2008.12.007","volume":"71","author":"SJ Proctor","year":"2009","unstructured":"Proctor SJ, Wilkinson J, Sieniawski M (2009) Hodgkin lymphoma in the elderly: a clinical review of treatment and outcome, past, present and future. Crit Rev Oncol Hematol 71:222\u2013232","journal-title":"Crit Rev Oncol Hematol"},{"key":"4039_CR3","unstructured":"Evens AM, Sweetenham J.W, Horning SJ. Hodgkin lymphoma in older patients: an uncommon disease in need of study. Oncology (Williston Park, NY) 2008;22:369\u2013379"},{"key":"4039_CR4","unstructured":"Klimm B, Diehl V, Engert A. Hodgkin\u2019s lymphoma in the elderly: a different disease in patients over 60. Oncology (Williston Park, NY) 2007;21:982\u2013990"},{"key":"4039_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bbmt.2017.09.006","volume":"24","author":"V Prochazka","year":"2018","unstructured":"Prochazka V, Gawande RS, Cayci Z et al (2018) Positron emission tomography-based assessment of metabolic tumor volume predicts survival after autologous hematopoietic cell transplantation for Hodgkin lymphoma. Biol Blood Marrow Transplant 24:64\u201370","journal-title":"Biol Blood Marrow Transplant"},{"key":"4039_CR6","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1182\/blood-2017-06-788877","volume":"130","author":"AJ Moskowitz","year":"2017","unstructured":"Moskowitz AJ, Schoder H, Gavane S et al (2017) Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma. Blood. 130:2196\u20132203","journal-title":"Blood."},{"key":"4039_CR7","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA, Alliance, Australasian Leukaemia and Lymphoma Group, Eastern Cooperative Oncology Group, European Mantle Cell Lymphoma Consortium, Italian Lymphoma Foundation, European Organisation for Research, Treatment of Cancer\/Dutch Hemato-Oncology Group, Grupo Espa\u00f1ol de M\u00e9dula \u00d3sea, German High-Grade Lymphoma Study Group, German Hodgkin's Study Group, Japanese Lymphorra Study Group, Lymphoma Study Association, NCIC Clinical Trials Group, Nordic Lymphoma Study Group, Southwest Oncology Group, United Kingdom National Cancer Research Institute (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059\u20133068","journal-title":"J Clin Oncol"},{"key":"4039_CR8","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, M\u00fceller SP, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O\u2019Doherty MJ, Hustinx R, Biggi A, Cheson BD (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the international conference on malignant lymphomas imaging working group. J Clin Oncol 32:3048\u20133058","journal-title":"J Clin Oncol"},{"key":"4039_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1053\/j.semnuclmed.2017.09.005","volume":"48","author":"L Kostakoglu","year":"2018","unstructured":"Kostakoglu L, Chauvie S (2018) Metabolic tumour volume metrics in lymphoma. Semin Nucl Med 48:50\u201366","journal-title":"Semin Nucl Med"},{"key":"4039_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00259-018-4173-2","volume":"46","author":"D Albano","year":"2019","unstructured":"Albano D, Bosio G, Pagani C, Re A, Tucci A, Giubbini R, Bertagna F (2019) Prognostic role of baseline 18F-FDG PET\/CT metabolic parameters in Burkitt lymphoma. Eur J Nucl Med Mol Imaging 46:87\u201396","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4039_CR11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s12149-018-1274-8","volume":"32","author":"D Albano","year":"2018","unstructured":"Albano D, Bertoli M, Battistotti M, Rodella C, Statuto M, Giubbini R, Bertagna F (2018) Prognostic role of pretreatment 18F-FDG PET\/CT in primary brain lymphoma. Ann Nucl Med 32:532\u2013541","journal-title":"Ann Nucl Med"},{"key":"4039_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s12149-019-01338-9","volume":"33","author":"D Albano","year":"2019","unstructured":"Albano D, Bosio G, Bianchetti N et al (2019) Prognostic role of baseline 18F-FDG PET\/CT metabolic parameters in mantle cell lymphoma. Ann Nucl Med 33:280\u2013287","journal-title":"Ann Nucl Med"},{"key":"4039_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/hon.2563","volume":"37","author":"D Albano","year":"2019","unstructured":"Albano D, Bosio G, Camoni L, Farina M, Re A, Tucci A, Giubbini R, Bertagna F (2019) Prognostic role of baseline 18F-FDG PET\/CT parameters in MALT lymphoma. Hematol Oncol 37:39\u201346","journal-title":"Hematol Oncol"},{"key":"4039_CR14","first-page":"6","volume":"5","author":"V Proch\u00e1zka","year":"2016","unstructured":"Proch\u00e1zka V, Klugar M, Bachanova V et al (2016) Comparing the accuracy of quantitative versus qualitative analyses of interim PET to prognosticate Hodgkin lymphoma: a systematic review protocol of diagnostic test accuracy. BMJ Open 5:6","journal-title":"BMJ Open"},{"key":"4039_CR15","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ et al (2015) FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 42:328\u2013354","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4039_CR16","doi-asserted-by":"publisher","unstructured":"Bentur OS, Dann EJ, Paran E, Lavie D, Nachmias B, Ron Y et al (2019) Interim PET-CT-guided therapy in elderly patients with Hodgkin lymphoma-a restroispective national multi-center study. Ann Hematol. https:\/\/doi.org\/10.1007\/s00277-019-03686-y","DOI":"10.1007\/s00277-019-03686-y"},{"key":"4039_CR17","doi-asserted-by":"publisher","first-page":"e2014050","DOI":"10.4084\/mjhid.2014.050","volume":"6","author":"A Thyss","year":"2014","unstructured":"Thyss A, Saada E, Gastaud L, Peyrade F, R\u00e9 D (2014) Hodgkin's lymphoma in older patients: an orphan disease? Mediterr J Hematol Infect Dis 6:e2014050","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"4039_CR18","unstructured":"Jagadeesh D, Diefenbach C, Evens AM (2013) XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomes. Hematol Oncol 69(Suppl 1):\u201375"},{"key":"4039_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/ejh.13090","volume":"101","author":"M Bj\u00f6rkholm","year":"2018","unstructured":"Bj\u00f6rkholm M, Weibull CE, Eloranta S, Smedby KE, Glimelius I, Dickman PW (2018) Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphoma-a population-based study from Sweden. Eur J Haematol 101:106\u2013114","journal-title":"Eur J Haematol"},{"key":"4039_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/annonc\/mdi023","volume":"16","author":"V Ballova","year":"2005","unstructured":"Ballova V, Ruffer JU, Haverkamp H et al (2005) A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin\u2019s disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly). Ann Oncol 16:124\u2013131","journal-title":"Ann Oncol"},{"key":"4039_CR21","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1200\/JCO.2012.47.3058","volume":"31","author":"AM Evens","year":"2013","unstructured":"Evens AM, Hong F (2013) How can outcomes be improved for older patients with Hodgkin lymphoma? J Clin Oncol 31:1502\u20131505","journal-title":"J Clin Oncol"},{"key":"4039_CR22","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1200\/JCO.2012.45.4181","volume":"31","author":"B B\u00f6ll","year":"2013","unstructured":"B\u00f6ll B, G\u00f6rgen H, Fuchs M, Pluetschow A, Eich HT, Bargetzi MJ, Weidmann E, Junghan\u00df C, Greil R, Scherpe A, Schmalz O, Eichenauer DA, von Tresckow B, Rothe A, Diehl V, Engert A, Borchmann P (2013) ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials. J Clin Oncol 31:1522\u20131529","journal-title":"J Clin Oncol"},{"key":"4039_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/bjh.12222","volume":"161","author":"AM Evens","year":"2013","unstructured":"Evens AM, Hong F, Gordon LI, Fisher RI, Bartlett NL, Connors JM, Gascoyne RD, Wagner H, Gospodarowicz M, Cheson BD, Stiff PJ, Advani R, Miller TP, Hoppe RT, Kahl BS, Horning SJ (2013) The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496. Br J Haematol 161:76\u201386","journal-title":"Br J Haematol"},{"key":"4039_CR24","doi-asserted-by":"crossref","unstructured":"Levis A, Anselmo AP, Ambrosetti A, Adamo F, Bertini M, Cavalieri E, Gavarotti P, Genua A, Liberati M, Pavone V, Pietrasanta D, Ricetti MM, Scalabrini DR, Salvi F, Vitolo U, Angelucci E, Boccadoro M, Gallo E, Mandelli F, Intergruppo Italiano Linfomi (IIL) Intergruppo Italiano Linfomi (IIL) (2004) VEPEMB in elderly Hodgkin\u2019s lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study. Ann Oncol 15:123\u2013128","DOI":"10.1093\/annonc\/mdh012"},{"key":"4039_CR25","doi-asserted-by":"publisher","first-page":"6005","DOI":"10.1182\/blood-2011-12-396556","volume":"119","author":"SJ Proctor","year":"2012","unstructured":"Proctor SJ, Wilkinson J, Jones G, Watson GC, Lucraft HH, Mainou-Fowler T, Culligan D, Galloway MJ, Wood KM, McNally RJQ, James PW, Goodlad JR (2012) Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study. Blood 119:6005\u20136015","journal-title":"Blood"},{"key":"4039_CR26","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1200\/JCO.2017.76.8093","volume":"36","author":"U D\u00fchrsen","year":"2018","unstructured":"D\u00fchrsen U, M\u00fcller S, Hertenstein B, Thomssen H, Kotzerke J, Mesters R, Berdel WE, Franzius C, Kroschinsky F, Weckesser M, Kofahl-Krause D, Bengel FM, D\u00fcrig J, Matschke J, Schmitz C, P\u00f6ppel T, Ose C, Brinkmann M, la Ros\u00e9e P, Freesmeyer M, Hertel A, H\u00f6ffkes HG, Behringer D, Prange-Krex G, Wilop S, Krohn T, Holzinger J, Griesshammer M, Giagounidis A, Raghavachar A, Maschmeyer G, Brink I, Bernhard H, Haberkorn U, Gaska T, Kurch L, van Assema DME, Klapper W, Hoelzer D, Geworski L, J\u00f6ckel KH, Scherag A, Bockisch A, Rekowski J, H\u00fcttmann A, on behalf of the PETAL Trial Investigators (2018) Positron emission tomography-guided therapy of aggressive non-Hodgkin lymphomas (PETAL): a multicenter, randomized phase III trial. J Clin Oncol 36:2024\u20132034","journal-title":"J Clin Oncol"},{"key":"4039_CR27","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00259-014-2783-x","volume":"41","author":"S Kanoun","year":"2014","unstructured":"Kanoun S, Rossi C, Berriolo-Riedinger A, Dygai-Cochet I, Cochet A, Humbert O, Toubeau M, Ferrant E, Brunotte F, Casasnovas RO (2014) Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 41:1735\u20131743","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4039_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s12885-018-4432-4","volume":"18","author":"JMM Rogasch","year":"2018","unstructured":"Rogasch JMM, Hundsdoerfer P, Hofheinz F, Wedel F, Schatka I, Amthauer H, Furth C (2018) Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin\u2019s lymphoma. BMC Cancer 18:521","journal-title":"BMC Cancer"},{"key":"4039_CR29","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1200\/JCO.19.00986","volume":"38","author":"DA Eichenauer","year":"2019","unstructured":"Eichenauer DA, Pl\u00fctschow A, Fuchs M, Sasse S, Baues C, B\u00f6ll B, von Tresckow B, Diehl V, Borchmann P, Engert A (2019) Long-term follow-up of patients with nodular lymphocyte-predominant Hodgkin lymphoma treated in the HD7 to HD15 trials: a report from the German Hodgkin Study Group. J Clin Oncol 38:698\u2013705. https:\/\/doi.org\/10.1200\/JCO.19.00986","journal-title":"J Clin Oncol"},{"key":"4039_CR30","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","volume":"35","author":"MPE Andr\u00e8","year":"2017","unstructured":"Andr\u00e8 MPE, Girinsky T, Federico M et al (2017) Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC\/LYSA\/FIL H10 trial. J Clin Oncol 35:1786\u20131794","journal-title":"J Clin Oncol"},{"key":"4039_CR31","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1200\/JCO.18.01799","volume":"37","author":"SF Barrington","year":"2019","unstructured":"Barrington SF, Philipps EH, Counsell N et al (2019) Positron emission tomography score has greater prognostic significance than pretreatment risk stratification in early-stage Hodgkin lymphoma in the UK RAPID study. J Clin Oncol 37:1732\u20131741","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04039-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-020-04039-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-020-04039-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T05:15:30Z","timestamp":1619327730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-020-04039-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["4039"],"URL":"https:\/\/doi.org\/10.1007\/s00277-020-04039-w","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]},"assertion":[{"value":"13 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}